ÐÂÎÅÖÐÐÄ
¼±ÐÔȱѪÐÔÄÔ×äÖУ¨AIS£©Êǵ¼ÖÂÈËÀàËÀÍöºÍÉ˲еÄÖØÒªÒòËØ£¬½âÎöÆäÄÚÔ´ÐÔµÄÐÞ¸´»úÖÆÊǽüÄêAISÖÎÁƵÄÈȵã¿ÎÌâÖ®Ò»¡£ÏÈÆÚÑо¿±êÃ÷£¬¶þ¼×»ù¾«°±Ëá¶þ¼×°·Ë®½âø1£¨DDAH1£©ÔÚ¶àÖÖ¼²²¡ÖУ¬ÈçÐÄѪ¹Üʼþ¡¢·ÇÖ¬·¾ÐԸβ¡±äÖпÉ×÷ΪӦ¼¤ÐÔÒò×Ó±¬·¢±£»¤×÷Óᣵ«Æä¶ÔAIS×÷Óõı¨µÀ½ÏÉÙ¡£½öÔÚ¶¯ÎïʵÑéÄ£ÐÍÉÏÑéÖ¤ÁËDDAH1ͨ¹ýµ÷Àí²î³Ø³ÆÐÔ¶þ¼×»ù¾«°±ËᣨADMA£©º¬Á¿¼õÇá´óÊó×äÖкó¼±ÐÔËðÉË£»ÒÔ¼°ÔÚϸ°û²ãÃæÉϼìÑé³ö²»ÒÀÀµADMAµÄ·½·¨µ÷¿ØÉñ¾Éú³¤Òò×Ó£¨NGF£©ÓÕµ¼µÄ´óÊóÉöÉÏÏÙÊȸõÁöPC12ϸ°ûµÄÆÊÎö×÷Ó᣶ø¶Ô×äÖкó»¼ÕßѪҺÄÚDDAH1µÄÁÙ´²¼ìÑé½á¹ûÒÔ¼°DDAH1¶Ô×äÖеÄÄÔËðÉËÐÞ¸´×÷Óþùδ¼û±¨µÀ¡£
Ê׶¼Ò½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÕØÓñÃ÷¸±½ÌÊÚ¡¢ÐûÎäÒ½ÔºÄÔѪ¹Ü²¡Ñо¿ËùÂÞÓñÃô½ÌÊÚºÍÖйú¿ÆѧԺ´óѧÉúÃü¿ÆѧԺ½ÖÒ±ø½ÌÊÚÏàÖúÔÚ¡°Acta Pharmaceutica Sinica B¡±Ðû²¼ÌâΪ¡°DDAH1 promotes neurogenesis and neural repair in cerebral ischemia¡±µÄÎÄÕ¡£ ×÷Õ߶ÔÄÔ×äÖл¼ÕßѪҺÄÚDDAH1±ä¸ïÓ뻼ÕßÄÔËðÉËˮƽÏà¹ØÐÔ¼°Æä¿ÉÄܼÓÈëµÄ×äÖÐÄÔËðÉ˵ÄÄÚÔÚ±£»¤×÷ÓýøÐÐÁË·Ö×Ó»úÖÆ̽ÌÖ¡£ÁÙ´²Ñо¿·¢Ã÷£¬×÷ΪӦ¼¤ÐÔ±£»¤Òò×Ó£¬DDAH1ÔÚȱѪÐÔÄÔ×äÖл¼ÕßѪÇåÖбí´ïÁ¿ÓëËðÉËˮƽ·ºÆðÕýÏà¹Ø£»¶¯ÎïÑо¿½øÒ»²½±êÃ÷: ȱѪÐÔÄÔ×äÖб¬·¢ºóDDAH1¿ÉÄÜͨ¹ýµÍÑõÓÕµ¼Òò×Ó-1¦Á/ÒÒõ£µ¨¼îתÒÆø£¨HIF-1¦Á/ChAT£©ÐźÅͨ·¶ÔÊÜËðµÄµ¨¼îÄÜÉñ¾½øÐÐÔÙÉúÐÔÐÞ¸´¡£ÏÔÈ»£¬Õâһз¢Ã÷ÓÐÍûΪȱѪÐÔ×äÖÐÖÎÁÆÌṩзÖ×Ӱе㼰ÐÂ˼·¡£ ±¾ÎÄʹÓÃTissueGnostics¹«Ë¾TissueFAXS PlusÈ«¾°×é֯ɨÃ趨Á¿ÆÊÎöϵͳ¶ÔСÊóÄÔ×éÖ¯½øÐжàÉ«ÃâÒßÓ«¹âͼÏñÊÕÂÞ¡£½èÖúTissue Cytometry¼¼Êõ£¬¶ÔСÊóÄÔ×éÖ¯²î±ð·ÖÇøµÄÄ¿±êÑôÐÔϸ°ûµÄ±í´ï½øÐÐÁ˾«×¼¶¨Á¿ÆÊÎö¡£ ±¾ÎÄÖУ¬×÷Õß½¨Á¢ÁËÒ»ÖÖ¹ØÓÚDDAH1µÄDZÔÚÖÎÁƼ°ÆÀ¹ÀÊֶΣ¬·¢Ã÷DDAH1µ÷ÀíÄÔ×äÖÐËðÉ˺󣬺£ÂíÖÐÂôÁ¦AChºÏ³ÉµÄ»ùÒò(Chat¡¢Slc5a7¡¢Slc18a3)ºÍAChŨ¶È¡£±¾ÎÄ×÷ÕßÔÚÒªº¦»·½Ú£¬Êý¾ÝУÑé¾ù½ÓÄɶàÉ«ÃâÒßÓ«¹â£¨mIHC£©¼¼Êõ£¬ÕâÖּƻ®Í¨¹ýÈý¼¶ÐźŷŴóµÄÔÀí£¬²»µ«¿ÉÒÔÌáÉýÊý¾Ý¼ì²âµÄÁéÃô¶È£¬»¹ÔÚÂú×ãÊý¾ÝУÑéͨÁ¿µÄÇ°ÌáÏ£¬¼«´óÌá¸ßÁËÊý¾ÝµÄ¿É¿¿¶ÈÓë¿ÉÐŶȡ£×÷ÕßÌåÏÖ£¬ÎÄÕÂ×î½¹µãµÄÒâÒåÔÚÓÚ£¬·¢Ã÷ACh½éµ¼Ï£¬DDAH1ÔÚ³ÉÈËÉñ¾ÔÙÉúµÄÉú̬λÖÐÆðÖØÒª×÷Óã¬ÊµÏÖÁËÔλ¿Õ¼äÌØÕ÷ÐÅÏ¢µÄ궨¡£ÕâÖÖ×÷ÓÿÉÄÜÖ±½ÓÓÕµ¼NSCsÔöÖ³£¬¼ä½ÓÔö½øNSCsÆÊÎöΪµ¨¼îÄÜÉñ¾Ôª£¬½øÒ»²½´Ì¼¤ÖÜΧNSCsµÄÔöÖ³¡£ÔöÇ¿µÄÉñ¾Ô´ÐÔ»îÐÔÓÐÖúÓÚÍ»´¥Ðγɺ͹¦Ð§»Ö¸´£¬ÒÔ¶Ô¿¹ÖзçË𺦣¬³ÉΪδÀ´»º½â¼°ÖÎÁÆÖзçµÄDZÔÚ·Ö×Ӱе㡣 Figure 3. DDAH1Ôö½øȱѪËðÉËÏÂÉñ¾¸Éϸ°û£¨NSCs£©µÄÔöÖ³¡£ (B)ͬ²àSVZºÍSGZÖÐDDAH1ºÍNestinÃâÒßÓ«¹âȾɫµÄ´ú±íÐÔͼÏñ¡£ (C)ͬ²àSVZºÍSGZÖÐBrdUºÍDCXÃâÒßÓ«¹âȾɫµÄ´ú±íÐÔͼÏñ¡£ (D, E)ͬ²àSVZºÍSGZµÄBrdUºÍDCXϸ°ûͳ¼ÆÆÊÎö(ÿ×én=4)¡£ Figure 4. DDAH1Ôö½øȱѪËðÉËÏÂÉñ¾¸Éϸ°û£¨NSCs£©µÄÉñ¾ÆÊÎö¡£ (B)ͬ²àSVZ¡¢ÎÆ×´ÌåºÍDGÖÐBrdUºÍNeuNÃâÒßÓ«¹âȾɫµÄ´ú±íÐÔͼÏñ¡£ (C, D)ͬ²àÎÆ×´Ìå(C)ºÍDG (D) BrdUºÍNeuNϸ°ûµÄͳ¼ÆÆÊÎö¡£ (E)ͬ²àSVZ¡¢ÎÆ×´ÌåºÍDGÖÐBrdUºÍGFAPÃâÒßÓ«¹âȾɫµÄ´ú±íÐÔͼÏñ¡£ (F, G)ͬ²àÎÆ×´ÌåºÍDG BrdUºÍGFAPϸ°ûµÄͳ¼ÆÆÊÎö¡£ (H, I)ÎÆ×´ÌåºÍDGÖÐBrdU¡¢NeuNºÍGFAPµÄ±í´ïÇé¿ö¡£ Figure 6. DDAH1ÔöÇ¿ÄÔ×äÖкóÉñ¾±¬·¢ÓÐÖúÓÚI1h/ R28dºóÈÏÖª¹¦Ð§»Ö¸´£¬µ«¶ÔÔ˶¯¹¦Ð§»Ö¸´Ã»ÓÐ×÷Óᣠ(J)ͬ²àSVZ¡¢ÎÆ×´ÌåºÍDG BrdUºÍNeuÃâÒßÓ«¹âȾɫµÄ´ú±íÐÔͼÏñ¡£ Figure 7.Éñ¾¸Éϸ°û£¨NSCs£©ÖÐDDAH1µÄÌõ¼þÇóý¿ÉÏû³ýÄÔ×äÖкóÉñ¾±¬·¢Ô˶¯²¢¼ÓÖØÈÏÖª¹¦Ð§ÕÏ°¡£ (F)ͬ²àSVZ¡¢ÎÆ×´ÌåºÍDGÖÐBrdUºÍNeuN/GFAPÃâÒßÓ«¹âȾɫµÄ´ú±íÐÔͼÏñ Figrure 9. DDAH1ÔÚËðÉ˺ó23Сʱµ÷ÀíSVZºÍSGZ Éñ¾¸Éϸ°û£¨NSCs£©ÖÐChATµÄ±í´ï¡£ (A) SVZºÍSGZÖÐChATºÍSOX2ÃâÒßÓ«¹âȾɫµÄ´ú±íÐÔͼÏñ¡£(B) (B, C) SVZºÍSGZÖÐChAT¡¢SOX2ϸ°ûµÄͳ¼ÆÆÊÎö(ÿ×én=3)¡£ ²Î¿¼ÎÄÕ£º¡¾APSBÂÛÎÄ¡¿ÄÔ×äÖкóÄÚÔ´ÐÔÔÙÉúÐÞ¸´µÄзÖ×Ӱеã¨CDDAH1 (qq.com)